首页> 外文期刊>Therapeutic Drug Monitoring >Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?
【24h】

Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?

机译:LC-MS是否适合全面筛查临床毒理学中的药物和毒物?

获取原文
获取原文并翻译 | 示例
           

摘要

This paper reviews the different attempts made to develop efficient LC-MS techniques for systematic toxicologic analysis, or general unknown screening (GUS) of drugs and toxic compounds. Only particle beam interfaces are compatible with electron ionization, but they mainly cover the same range of compounds as GC-MS, i.e. nonpolar, thermally stable molecules. Using the more used electrospray sources, several approaches were used: tandem-mass spectrometry (MS/MS); MS/MS with data-dependent or information-dependent acquisition (DDA or IDA); and single mass spectrometry with in-source collision induced dissociation (CID). The MS/MS strategy is not really compatible with a GUS procedure, as it requires selecting a limited number of ions in the first step, before fragmenting them. DDA or IDA are auto-adaptive MS/MS product-ion scan modes where the m/z ratios the intensity of which is above a given threshold are selected at each unit time. Preliminary studies showed their potential for GUS, but it will probably be necessary to improve the detection of signals of toxicologic interest among background noise. This is also the case for single-MS techniques with in-source CID. Such methods have been proposed by several teams, who demonstrated their repeatability and reproducibility, at least on a same type of instrument and on an intralaboratory basis. Optimized extraction procedures are necessary to recover polar and even hydrophilic drugs, which are those supposed to be detectable by LC-ES-MS and not GC-MS, and such nonselective extraction may be responsible for high chemical noise. Chromatographic conditions and the resulting separation, resolution and signal-to-noise ratio are also probably important determinants of the efficiency of such procedures. Preliminary results using an optimized LC-ES-MS GUS technique showed that it is probably as efficient as GC-MS or HPLC-DAD for the detection of drugs and toxicants in clinical serum samples and that it is complementary to both these techniques.
机译:本文回顾了为开发有效的LC-MS技术进行系统毒理学分析或药物和有毒化合物的一般未知筛选(GUS)所做的不同尝试。仅粒子束界面与电子电离兼容,但它们主要覆盖与GC-MS相同范围的化合物,即非极性,热稳定分子。使用更多使用的电喷雾源时,使用了几种方法:串联质谱(MS / MS);具有数据相关或信息相关采集(DDA或IDA)的MS / MS;和具有源内碰撞诱导解离(CID)的单质谱。 MS / MS策略实际上与GUS程序不兼容,因为它需要在第一步之前选择数量有限的离子,然后再将其碎片化。 DDA或IDA是自适应MS / MS乘积离子扫描模式,其中在每个单位时间选择强度高于给定阈值的m / z比。初步研究表明它们具有GUS的潜力,但可能有必要改善背景噪声中对毒理学感兴趣的信号的检测。具有源内CID的单MS技术也是如此。几个小组提出了这样的方法,他们证明了它们的可重复性和可重复性,至少在相同类型的仪器上和在实验室内为基础。优化的提取程序对于回收极性药物甚至亲水性药物是必要的,而极性药物甚至亲水性药物被认为可以通过LC-ES-MS而非GC-MS检测到,这种非选择性提取可能会导致高化学噪音。色谱条件以及所产生的分离度,分离度和信噪比也可能是此类程序效率的重要决定因素。使用优化的LC-ES-MS GUS技术的初步结果表明,它在检测临床血清样品中的药物和有毒物质方面可能与GC-MS或HPLC-DAD一样有效,并且与这两种技术互补。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号